Ang II increased superoxide generation in isolated normal glomeruli in a dose-dependent manner, and coincubation with olmesartan, an angiotensin type 1 receptor blocker, suppressed such increase. Subtotal nephrectomized rats (Nx, n =8) showed impaired renal function, increased glomerular sclerosis, and significantly high superoxide production in glomeruli. These changes were inhibited in olmesartan-treated (n =8), but not hydralazine-treated (n =8) Nx rats. Oxidative stress and nitrosative stress were observed in Nx glomeruli, as evidenced by increased levels of carbonyl protein and nitrotyrosine formation, respectively. These changes were inhibited by 8-week treatment with olmesartan. The apoptosis observed in Nx glomeruli was also suppressed by olmesartan. Superoxide generation in Nx glomeruli was blocked by an NAD(P)H oxidase inhibitor, diphenylene iodinium. The mRNA expression levels of two NAD(P)H oxidase subunits were increased in Nx, and olmesartan significantly reduced the mRNA expression levels. These results indicate that Ang II directly induced superoxide production through activation of NAD(P)H oxidase, and olmesartan would inhibit superoxide production and oxidative stress independent of its blood pressure-lowering effect. 
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Olmesartan Ameliorates Progressive Glomerular Injury in Subtotal Nephrectomized Rats through Suppression of Superoxide Production
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Introduction
Angiotensin II (Ang II) plays a role in the induction of glomerular injury, and upregulation of the local tissue reninangiotensin-system (RAS) in response to injury has been demonstrated in renal diseases (1) . Blockade of the RAS with either angiotensin-converting enzyme (ACE) inhibitors or angiotensin type 1 receptor (AT1R) blockers (ARBs) results in improvement of proteinuria and slowing of the progression of chronic kidney disease. These effects of RAS inhibition are in addition to, but independent of blood pressure control (2, 3) . These clinical studies as well as a large number of in vivo (4, 5) and in vitro (6, 7) experimental studies support the notion that the nonhemodynamic effects of Ang II are pathophysiologically important in progressive glomerular injury.
Ang II regulates and increases NAD(P)H oxidase-dependent superoxide production in cultured vascular smooth muscle cells (8) , fibroblasts (9) , endothelial cells (10) , cardiomyocytes (11) , and mesangial cells (12) . There is evidence to suggest that intracellular production of reactive oxygen species (ROS), including superoxide, mediates Ang II-dependent cellular responses via activation of redox-sensitive signaling cascades (13) (14) (15) . Thus, the renoprotective effects of ARBs are mediated through inhibition of glomerular ROS generation in chronic kidney disease. However, the functional and pathophysiological roles of oxidative stress in chronic kidney disease have been gessed based only on the presence of high levels of lipid peroxides in the kidneys of subtotal nephrectomized rats (16) . To our knowledge, no direct evidence for the presence of oxidative stress in glomeruli has been reported. In the present study, we provide evidence for the presence of excessive oxidative stress in the glomeruli of subtotal nephrectomized rats using a fluorescent dye, dihydroethidium (DHE), which has been used to estimate the formation of superoxide. We also report on the effect of olmesartan, an ARB, on ROS production in the glomeruli of the same rat model.
Methods

Detection of Superoxide in Normal Glomeruli
Exposed to Ang II Superoxide production was detected by DHE staining (17) and 2′,7′-dichlorofluorescein (DCF) staining (18) . Isolated glomeruli from 8-week-old male Wistar rats were first incubated with RPMI-1640 containing 20 μmol/L DHE for 1 h or 2′,7′-dichlorofluorescein diacetate (DCFH-DA: Molecular Probes, Eugene, USA) for 10 min and rinsed with phosphatebuffered saline. The glomeruli were exposed to Ang II (0.1 to 1,000 nmol/L) or 100 nmol/L Ang II for 1 h with 100 nmol/L olmesartan, or 100 nmol/L PD123319, an angiotensin type 2 receptor (AT2R) blocker, before exposure to the experimental conditions. Fluorescence images were obtained using a confocal laser microscope (Leica Microsystems, Tokyo, Japan) at excitation/emission wavelengths of 485/535 nm for DCF and 535/610 nm for DHE, respectively. The fluorescence intensity values from 50 different isolated glomeruli were calculated by Leica TCS-NT software (Leica Microsystems) and the average values are presented.
Animals
The experimental protocol was approved by the Ethics Review Committee for Animal Experimentation of Kawasaki Medical School, Kurashiki, Japan. Male Wistar rats weighing 250-300 g were used in this experiment. Subtotal (fivesixths) nephrectomy was performed under anesthesia, by removal of the right kidney and ligation of two branches of the left renal artery, resulting in infarction of approximately two-thirds of the left kidney. Following subtotal nephrectomy, the rats were divided into three groups: a no-treatment group (Nx group, n= 8), an olmesartan group (Nx +OLM group; 5 mg/kg/day, n= 8) and a hydralazine group (Nx+HYD group; 5 mg/kg/day, n= 8). The treatment groups received the respective medication for 8 weeks, commencing immediately after surgery. Sham-operated rats were used as the control group (sham group, n= 8).
Renal Function and Morphological Study
After 8 weeks of treatment, rats were placed in metabolic cages for 24 h to collect urine samples. Rats undergoing urinary collection were fed no food, but were given tap water. After the final 24-h fasting in metabolic cages, blood samples were obtained from rats via an 18-gauge needle inserted into the left ventricle after the rats were killed (19) . Before sacrification, the femoral artery was catheterized with polyethylene tubes (PE-50; Becton Dickinson, Parsippany, USA) and systolic blood pressure was recorded under sevoflurane inhalation anesthesia. Serum creatinine and 24-h urinary protein excretion were examined in each group at 8 weeks following subtotal nephrectomy. Removed rat kidney sections were stained with periodic acid-Schiff. In each group, the percentage of those exhibiting segmental sclerosis in 30 glomerular sections was determined and expressed as a glomerular sclerosis index. Glomerular sclerosis was graded semiquantitatively in each glomerulus using a scale of 0 to 3: 0, no glomerular sclerosis; 1, segmental glomerular sclerosis in < 25% of glomeruli; 2, segmental glomerular sclerosis in 25% to 50% of glomeruli; and 3, segmental glomerular sclerosis in > 50% of glomeruli. The mean score per glomerulus was determined for each rat and reported as the glomerular sclerosis index.
Determination of Superoxide Production in Glomeruli of Nephrectomized Rats
Isolated glomeruli from each group were incubated in RPMI-1640 containing 20 μmol/L DHE for 1 h and rinsed with phosphate-buffered saline. Some experiments were performed with 30 min pre-incubation by 100 μmol/L diphenylene iodinium (DPI), 1 mmol/L allopurinol or 100 μmol/L 4,4′-diisothiocyano-2,2′-stilbenedisulfonic acid (DIDS). In each model, the mean fluorescence intensity of isolated glomeruli was analyzed by TCS-NT (Leica Microsystems).
Western Blotting
Proteins extracted from isolated glomeruli were used for carbonyl protein and nitrotyrosine immunoblotting. Western blot analysis for carbonyl protein was performed with an Oncor Oxyblot kit, according to the protocol provided by the manu- facturer (Oncor, Gaithersburg, USA). Extracted proteins (50 μg) were separated in a 7.5% SDS-polyacrylamide gel and then transferred onto a polyvinylidene difluoride membrane. The membranes were incubated for 1 h with anti-nitrotyrosine antibody (Upstate Biotechnology, Lake Placid, USA). Bands were visualized using the ECL-plus Western blotting detection system (Amersham Biosciences, Piscataway, USA).
Quantitative Real-Time Polymerase Chain Reaction
Total RNA was extracted from the isolated glomeruli by using TRIzol reagent (Invitrogen Japan, Tokyo, Japan). Quantitative real-time polymerase chain reaction (PCR) was performed using the TaqMan Universal PCR Master Mix (Applied Biosystems, Foster City, USA) with an Applied Biosystems Sequence Detector 7700. The primers and probes for p22phox, p47phox (20) , angiotensinogen (NM_134432), ACE1 (AF201332) and AT1R (BC078810) were as follows. For p22phox: 5′-CTTTGGTGCTTACTCTATTGTTGCA-3′
(forward probe), 5′-GGAGCCCTTTTTCCTCTTTCC-3′ (reverse probe), and 5′-FAM-TGCTCATCTGTCTGCTGG AGTACCCCC-TAMRA-3′ (TaqMan probe); for p47phox: 5′-GTGAAGCCATCGAGGTCATTC-3′ (forward), 5′-CCC GCGGCTTCTAATCTGT-3′ (reverse), and 5′-FAM-CAT CACCGGCTACTTCCCATCCATGT-TAMRA-3′ (TaqMan); for angiotensinogen: 5′-GATAAAGAACCCGCCTC CTC-3′ (forward), 5′-GGTAGACAGCTTGGCCTGAG-3′ (reverse), and 5′-FAM-AATTCGGGGATCCTACAACC-BHQ-3′ (TaqMan); for ACE: 5′-GAGTCGATGCTGGAG AAACC-3′ (forward), 5′-CGTGCACTGCTTAATCCTGA-3′ (reverse), and 5′-FAM-CCTCTGCGTGGGACTTCTAC-BHQ3′ (TaqMan); and for AT1R: 5′-GGAAACAGCTTG GTGGTGAT-3′ (forward), 5′-ATAAGTCAGCCAAGGC GAGA-3′ (reverse), and 5′-FAM-AAGCTGAAGACTGTG GCCAG-BHQ-3′ (TaqMan).
Assessment of Glomerular Apoptosis
Apoptotic nuclei were detected with the terminal deoxy- 
Statistical Analysis
Values were expressed as the means±SD. 
Results
DHE generates fluorescence upon exposure to superoxide, while DCFH-DA generates fluorescence upon exposure to peroxides, including H2O2 and peroxynitrite. In the ex vivo study, exposure of isolated normal glomeruli to Ang II (0.1 to 1,000 nmol/L) resulted in a significant dose-dependent increase in fluorescence intensity (Fig. 1) . Ang II-induced glomerular superoxide generation was blocked by olmesartan, but not by PD123319 (Fig. 1 ). There were no changes in the mRNA expression levels of the NAD(P)H oxidase component. These results suggest that the action of Ang II on superoxide production was mediated via AT1R, but not AT2R.
In the in vivo study, Nx rats showed chronic renal impairment characterized by elevated serum creatinine and severe proteinuria (Table 1) . These changes were reduced by treatment with olmesartan, but not with hydralazine. The glomerular sclerosis index was higher in the Nx group than the sham group. The high index was reduced by olmesartan treatment, but not hydralazine treatment.
The fluorescence of isolated glomeruli from the Nx group was significantly stronger than that of glomeruli from the sham group. The fluorescence intensity of isolated glomeruli from rats of the Nx+OLM group was lower than that of the sham group ( Fig. 2A, B) . Treatment with hydralazine tended to reduce the fluorescence intensity by 22%, albeit insignificantly. Glomerular superoxide generation in the Nx group was blocked by DPI, an NAD(P)H oxidase inhibitor, but not by allopurinol, a xanthine oxidase inhibitor, or DIDS, a mitochondrial anion channel inhibitor (Fig. 2C) . These results suggest that superoxide production in isolated glomeruli from Nx rats was mediated via NAD(P)H oxidase activation rather than via xanthine oxidase or mitochondrial pathway. The p22phox is a membrane component while p47phox is a cytosolic component of NAD(P)H oxidase. Both mRNAs were increased in isolated glomeruli of Nx rats (Fig. 3A, B) . Olmesartan significantly reduced the expression levels of both mRNAs to the levels seen in the sham rats. However, hydralazine had no effect on p22phox mRNA. On the other hand, hydralazine significantly reduced p47phox mRNA expression, but the level was still higher than that of the sham group (Fig. 3B) .
Fig. 3. Analysis of real-time PCR in isolated glomeruli. Expression levels of p22phox mRNA (A), p47phox mRNA (B), angiotensinogen (C), ACE (D) and AT1R (E)
The angiotensinogen mRNA and ACE mRNA expressions in isolated glomeruli from Nx rats were significantly increased compared with those from sham rats. Olmesartan, but not hydralazine, significantly reduced these expressions (Fig. 3C, D) . The AT1R mRNA expression was significantly reduced in Nx glomeruli, and treatment with olmesartan, but not hydralazine, significantly increased the AT1R mRNA (Fig. 3E) .
Carbonyl protein levels in glomeruli of Nx rats were higher than those of the sham group (Fig. 4A) . Olmesartan, but not hydralazine, significantly reduced glomerular carbonyl protein levels. The reaction of nitric oxide with superoxide (to form peroxynitrite) occurs six times faster than the superoxide dismutase reaction with superoxide (21) . Peroxynitrite is more stable than nitric oxide and exerts multiple cytotoxic effects, some of which involve formation of protein-associated nitrotyrosine (22) . Nitrotyrosine formation in Nx rats was higher than in rats of the sham group, and was reduced in rats of the Nx+OLM group (Fig. 4B) . Nitrotyrosine formation was also reduced in the Nx+HYD group compared with the Nx group, but the level was higher than that in the sham group.
Apoptosis was assessed by TUNEL staining (Fig. 5) . The percentage of apoptotic cells in glomeruli was higher in the 
Fig. 4. Oxidative stress markers in glomeruli of nephrectomized rats. A: Western blot of carbonyl group proteins in isolated glomeruli (top) and quantitative analysis of the results (bottom
Discussion
In the Nx rat model, previous studies have demonstrated the prevention or inhibition of the glomerular and tubular injury by an antioxidant such as α-tocopherol (23) or N-acetylcysteine (24) . There are also many reports that ARBs have renoprotective effects in the Nx rat model (25, 26) . However, there have been few reports on the effects of ARBs from the viewpoint of the oxidation stress reduction. Olmesartan has been reported to improve endothelin-induced hypertension and oxidative stress in rats (27) . We therefore hypothesized that olmesartan would ameliorate renal injury in the Nx rat model through suppression of superoxide production. Here, we first showed that Ang II-induced superoxide production in isolated glomeruli and that olmesartan reduced Ang IIinduced superoxide production both ex vivo and in vivo. Second, we explored the effect of olmesartan on superoxide production in the glomeruli of rats with experimentally-induced chronic kidney disease and used hydralazine to ensure that the effect of olmesartan on superoxide production was independent of its blood pressure-lowering effects. Based on these results, we propose that olmesartan may have renoprotective effects and these effects may be mediated through blockade of Ang II-induced superoxide production. In this study, we found that Ang II induced a dose-dependent increase of superoxide production in isolated normal glomeruli. Olmesartan as well as DPI blocked Ang II-stimulated glomerular superoxide production, indicating that Ang II increases superoxide accumulation via the Ang II-AT1R-NAD(P)H oxidase system. Although the origin of the increased superoxide generation in renal diseases is multifactorial, the kidney is known to express NADPH oxidase and generate ROS (20, 28) . Ang II induces NAD(P)H oxidasedependent superoxide production by mesangial cells (12) . Ang II also induces endothelial cell NAD(P)H oxidase activation (29) . The mRNAs of the NAD(P)H oxidase subunits p22phox, p47phox, gp91phox, and p67phox are detected in podocytes (17) . Thus, all components of glomeruli contain NAD(P)H oxidase and they can all produce superoxide in response to Ang II.
We also provided evidence for the presence of excessive oxidative stress in the glomeruli of Nx rats. Subtotal renal ablation is a commonly used experimental model to study progressive renal damage in susceptible rat strains. Functional adaptive changes in the remaining nephrons, induced by abrupt reduction in renal mass, are eventually deleterious to renal function because of pressure-induced capillary stretch and glomerular injury. The hyperfiltering state-associated glomerular capillary hypertension upregulates local expression of the RAS (30) , and it would cause superoxide production. Increased superoxide formation may occur in chronic kidney disease for reasons possibly related to an increase in glomerular hypertension. In our experiment, postoperative treatment of rats with olmesartan for 8 weeks completely diminished superoxide production. As shown in previous studies, the sensitivity to Ang II is higher in the postglomerular efferent than in preglomerular afferent arterioles (31, 32) . Thus, Ang II blockade may dilate efferent arterioles, thereby lowering glomerular capillary pressure, and causing a reduction in NAD(P)H oxidase expression and superoxide production. Moreover, glomeruli of hydralazine-treated Nx rats showed a slight reduction in the expression of p47phox and production of superoxide. Systolic blood pressure was significantly reduced in hydralazine-treated rats, and thus the glomerular pressure was decreased in proportion to the reduction in systemic blood pressure, which may have caused the slight reduction in superoxide production.
We examined whether glomerular RAS components are activated in Nx glomeruli. The mRNA expressions of angiotensinogen and ACE were increased in Nx and attenuated by olmesartan treatment. The mRNA expression of AT1R was decreased in Nx glomeruli and normalized by ARB, which was consistent with a previous report (33) . These data would Treatment with olmesartan reduced the accumulation of carbonyl protein and nitrotyrosine in the glomeruli and such reduction was proportionate to the reduction in superoxide production. The rapid reaction of superoxide with nitric oxide (NO) generates peroxynitrite and diminishes the bioactivity of NO. Peroxynitrite is too reactive to measure directly, but peroxynitrite stably nitrates aromatics such as tyrosine residues in proteins such as 3-nitrotyrosine (34) . We previously showed that reduction of nitrosative stress improved hypertensive renal injury (19) . Within the glomerulus, a decrease in NO bioactivity would reduce the homeostatic role of NO in antagonizing Ang II-driven growth-related processes affecting the mesangial cells and extracellular matrix as well as the role of NO in preventing platelet and leukocyte adhesion to the endothelium (35) . Thus, one of the pleiotropic benefits of olmesartan beyond its blood pressure-lowering effect may be suppression of nitrotyrosative stress.
We also showed that olmesartan treatment decreased apoptosis in Nx glomeruli. Apoptosis of glomerular cells has been demonstrated in human diseases (36) and experimental models of the remnant kidney (36), diabetes (37) , and hypertensive nephrosclerosis (38) , where increased activity of Ang II may be implicated. Furthermore, it has been reported that ROS induce apoptosis in mesangial cells (39) and podocytes (40) . Falls in numbers of mesangial cells and podocytes correlate with progression to glomerulosclerosis (41, 42) . Considered together, these results indicate that the pleiotropic benefits of olmesartan, which reduce oxidative stress, might be mediated by suppression of apoptosis.
In summary, we have demonstrated in the present study that Ang II induced superoxide production in isolated glomeruli and that olmesartan reduced superoxide production both ex vivo and in vivo. We also provided evidence for the presence of excessive oxidative stress in glomeruli of subtotal nephrectomized rats and that olmesartan suppressed ROS production in glomeruli. These findings could support the notion that oxidative stress plays a primary role in the glomerular pathogenesis of chronic kidney disease.
